Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOMAX vs HYTRIN in BPH
NCT02244255Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 1998
- Primary completion
- Jun 2000
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tamsulosin in benign prostatic hyperplasia (BPH), sponsored by Boehringer Ingelheim. Started Aug 1998; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02244255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244255.